Delivery Order SPE2DB22D2211-SPE2DB25FSCAD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,129.70 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply fulfillment under AmerisourceBergen's broader relationship with the federal government. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,677.58 to AmerisourceBergen Drug Corp for Bridion 200 mg/2 mL vials on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, represents a small-value transaction for a pharmaceutical product commonly used in anesthesia and critical care settings. The place of performance is listed as Conshohocken, Pennsylvania, which...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This firm fixed-price delivery order, valued at $1,577.68, represents a competitively awarded contract with an ultimate completion date of July 22, 2025. The award was issued without a set-aside designation, reflecting AmerisourceBergen's demonstrated capability to compete for federal medical procurement requirements....
- The Defense Logistics Agency awarded a delivery order valued at $2,660.34 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Bridion is a pharmaceutical product used in clinical settings, and this delivery order...
- The Defense Logistics Agency (DLA) awarded a $30,552.77 delivery order to AmerisourceBergen Drug Corp for the supply of Bridion 500 mg/5 mL vials on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $20,061.21 to AmerisourceBergen Drug Corp for the supply of Bridion 200 mg/2 mL vials on July 23, 2025, with completion scheduled for July 24, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this delivery order from its corporate office location. This...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,673.61 to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Bridion 200 mg/2 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. The award represents a continuation of...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $131,234.68 on July 29, 2025, for the supply of Bridion 200mg/2mL (10 units). This competitively awarded, firm fixed price contract is not set-aside and will be completed by August 25, 2025. The award is funded by the Defense Logistics Agency's Medical Supply Chain division and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bridion 200mg/2ml, a pharmaceutical product, with a ceiling value of $34,244.12. The contract is a firm fixed price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
- AmerisourceBergen Drug Corp received a $4,798.93 firm fixed price delivery order from the Defense Logistics Agency (DLA) on July 21, 2025, for Bridion 200 mg/2 ml vials. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 22, 2025. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCADDelivery Order
The Defense Logistics Agency awarded a $19,114.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Bridion 200 mg/2 ml vials, with an ultimate completion date of August 4, 2025. This non-set-aside award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania, supporting federal medical procurement needs within the Defense Logistics Agency's supply chain. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract supports critical customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a key vendor for federal medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $19.1k | 8/1/25 |